Nab-paclitaxel Dose Schedual for HER-2 Negative Advanced Breast Cancer
Clinical trial NCT04192331 · UNKNOWN
Trial details
- NCT number
- NCT04192331
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-21
- Primary completion
- 2023-01-26
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.